Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

User Preferences for Improving the Estonian National e-Prescription Service.

Parv L, Monkman H, Laus R.

Stud Health Technol Inform. 2015;218:15-19.

PMID:
26262520
2.

Competitive adsorption of Cu(II) and Cd(II) ions by chitosan crosslinked with epichlorohydrin-triphosphate.

Laus R, de Fávere VT.

Bioresour Technol. 2011 Oct;102(19):8769-76. doi: 10.1016/j.biortech.2011.07.057. Epub 2011 Jul 22.

3.

Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells.

Mandl SJ, Rountree RB, Dalpozzo K, Do L, Lombardo JR, Schoonmaker PL, Dirmeier U, Steigerwald R, Giffon T, Laus R, Delcayre A.

Cancer Immunol Immunother. 2012 Jan;61(1):19-29. doi: 10.1007/s00262-011-1077-4. Epub 2011 Aug 7.

4.

Exosome targeting of tumor antigens expressed by cancer vaccines can improve antigen immunogenicity and therapeutic efficacy.

Rountree RB, Mandl SJ, Nachtwey JM, Dalpozzo K, Do L, Lombardo JR, Schoonmaker PL, Brinkmann K, Dirmeier U, Laus R, Delcayre A.

Cancer Res. 2011 Aug 1;71(15):5235-44. doi: 10.1158/0008-5472.CAN-10-4076. Epub 2011 Jun 13.

5.

Adsorption and desorption of Cu(II), Cd(II) and Pb(II) ions using chitosan crosslinked with epichlorohydrin-triphosphate as the adsorbent.

Laus R, Costa TG, Szpoganicz B, Fávere VT.

J Hazard Mater. 2010 Nov 15;183(1-3):233-41. doi: 10.1016/j.jhazmat.2010.07.016. Epub 2010 Jul 13.

PMID:
20674156
6.

A flow cytometry-based immuno-titration assay for rapid and accurate titer determination of modified vaccinia Ankara virus vectors.

Li Z, Ling L, Liu X, Laus R, Delcayre A.

J Virol Methods. 2010 Oct;169(1):87-94. doi: 10.1016/j.jviromet.2010.07.003. Epub 2010 Jul 14.

PMID:
20637240
7.

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.

Kantoff PW, Schuetz TJ, Blumenstein BA, Glode LM, Bilhartz DL, Wyand M, Manson K, Panicali DL, Laus R, Schlom J, Dahut WL, Arlen PM, Gulley JL, Godfrey WR.

J Clin Oncol. 2010 Mar 1;28(7):1099-105. doi: 10.1200/JCO.2009.25.0597. Epub 2010 Jan 25.

8.

Textile effluents induce biomarkers of acute toxicity, oxidative stress, and genotoxicity.

Grinevicius VM, Geremias R, Laus R, Bettega KF, Laranjeiras MC, Fávere VT, Wilhelm Filho D, Pedrosa RC.

Arch Environ Contam Toxicol. 2009 Aug;57(2):307-14. doi: 10.1007/s00244-008-9263-x. Epub 2008 Dec 4.

PMID:
19052797
9.

Use of coal mining waste for the removal of acidity and metal ions Al (III), Fe (III) and Mn (II) in acid mine drainage.

Geremias R, Laus R, Macan JM, Pedrosa RC, Laranjeira MC, Silvano J, Fávere FV.

Environ Technol. 2008 Aug;29(8):863-9. doi: 10.1080/09593330802015409.

PMID:
18724641
10.

Reduction of acidity and removal of metal ions from coal mining effluents using chitosan microspheres.

Laus R, Geremias R, Vasconcelos HL, Laranjeira MC, Fávere VT.

J Hazard Mater. 2007 Oct 22;149(2):471-4. Epub 2007 Apr 6.

PMID:
17499431
11.

Evaluation of remediation of coal mining wastewater by chitosan microspheres using biomarkers.

Benassi JC, Laus R, Geremias R, Lima PL, Menezes CT, Laranjeira MC, Wilhelm-Filho D, Fávere VT, Pedrosa RC.

Arch Environ Contam Toxicol. 2006 Nov;51(4):633-40. Epub 2006 Sep 18.

PMID:
16988869
12.

Tumor immunotherapy with alternative reading frame peptide antigens.

Graddis TJ, Diegel ML, McMahan CJ, Tsavler L, Laus R, Vidovic D.

Immunobiology. 2004;209(7):535-44. Erratum in: Immunobiology. 2005;209(10):753. Graddis, Thomas J [added]; Diegel, Michael L [added]; McMahan, Catherine J [added]; Tsavler, Larisa [added]; Laus, Reiner [added].

PMID:
15568617
13.

Use of chitosan microspheres as remedial material for acidity and iron (III) contents of coal mining wastewaters.

Fávere VT, Laus R, Laranjeira MC, Martins AO, Pedrosa RC.

Environ Technol. 2004 Aug;25(8):861-6.

PMID:
15366552
14.
15.

Specific stimulation of MHC-transgenic mouse T-cell hybridomas with xenogeneic APC.

Vidovic D, Graddis TJ, Stepan LP, Zaller DM, Laus R.

Hum Immunol. 2003 Feb;64(2):238-44.

PMID:
12559626
16.

Antitumor vaccination with HER-2-derived recombinant antigens.

Vidovic D, Graddis T, Chen F, Slagle P, Diegel M, Stepan L, Laus R.

Int J Cancer. 2002 Dec 20;102(6):660-4.

17.

Dendritic cell-based treatment of cancer: closing in on a cellular therapy.

Valone FH, Small E, MacKenzie M, Burch P, Lacy M, Peshwa MV, Laus R.

Cancer J. 2001 Nov-Dec;7 Suppl 2:S53-61.

PMID:
11777265
19.
20.

Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells.

Small EJ, Fratesi P, Reese DM, Strang G, Laus R, Peshwa MV, Valone FH.

J Clin Oncol. 2000 Dec 1;18(23):3894-903.

PMID:
11099318
21.

In vivo persistence of donor cells following adoptive transfer of allogeneic dendritic cells in HIV-infected patients.

Shapero MH, Kundu SK, Engleman E, Laus R, van Schooten WC, Merigan TC.

Cell Transplant. 2000 May-Jun;9(3):307-17.

PMID:
10972330
22.

Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer.

Burch PA, Breen JK, Buckner JC, Gastineau DA, Kaur JA, Laus RL, Padley DJ, Peshwa MV, Pitot HC, Richardson RL, Smits BJ, Sopapan P, Strang G, Valone FH, Vuk-Pavlović S.

Clin Cancer Res. 2000 Jun;6(6):2175-82.

23.

In Vivo Persistence of Donor Cells following Adoptive Transfer of Allogeneic Dendritic Cells in HIV-Infected Patients.

Shapero MH, Kundu SK, Engleman E, Laus R, Van Schooten WCA, Merigan TC.

Cell Transplant. 2000 May;9(3):307-317. doi: 10.1177/096368970000900302.

PMID:
28880658
24.
25.
26.

B4B, a novel growth-arrest gene, is expressed by a subset of progenitor/pre-B lymphocytes negative for cytoplasmic mu-chain.

Ruegg CL, Wu HY, Fagnoni FF, Engleman EG, Laus R.

J Immunol. 1996 Jul 1;157(1):72-80.

PMID:
8683158
27.

V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.

Ruegg CL, Rivas A, Madani ND, Zeitung J, Laus R, Engleman EG.

J Immunol. 1995 May 1;154(9):4434-43.

PMID:
7722300
28.

V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.

Rivas A, Ruegg CL, Zeitung J, Laus R, Warnke R, Benike C, Engleman EG.

J Immunol. 1995 May 1;154(9):4423-33.

PMID:
7722299
29.

Characterization of a novel cell surface molecule discovered on human peripheral blood lymphocytes achieved by a new, rapid technique for identification of molecules with transmembrane regions.

Zenz KI, Laus R, Herwartz C, Steinmann J, Müller-Ruchholtz W.

Transplant Proc. 1994 Dec;26(6):3494-5. No abstract available.

PMID:
7998244
30.

New parental cell lines for generating human hybridomas.

Hundhausen T, Laus R, Müller-Ruchholtz W.

J Immunol Methods. 1992 Aug 30;153(1-2):21-9.

PMID:
1517591
31.

Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.

Rivas A, Koide J, Laus R, Engleman EG.

J Immunol. 1990 Jul 15;145(2):470-6.

PMID:
2142178
32.

A human-mouse T-cell hybridoma-derived lymphokine inhibits thymidine uptake of T-lymphocytes.

Laus R, Müller-Ruchholtz W.

Transplant Proc. 1989 Feb;21(1 Pt 1):96-7. No abstract available.

PMID:
2784914
33.

Carbohydrate-specific human heterophile antibodies in normal human sera that react with xenogeneic cells.

Laus R, Ulrichs K, Müller-Ruchholtz W.

Int Arch Allergy Appl Immunol. 1988;85(2):201-7.

PMID:
3338860

Supplemental Content

Support Center